EPA chief Lee Zeldin just hit reset on paraquat, telling makers like Syngenta to deliver fresh human-exposure data or risk new restrictions that could upend weed-control practices across 120 million U.S. row-crop acres.
What happened
EPA Administrator Lee Zeldin used a Friday post on X to announce a full safety reassessment of paraquat, one of the most potent herbicides still legal in the United States. The move requires current registrants—chief among them Syngenta with its Gramoxone brand—to produce “real-world” evidence that every approved use is safe for workers, bystanders and consumers.
Why it matters now
- 120 million acres of soy, corn and cotton rely on paraquat for burn-down and resistance management.
- More than 5,000 Parkinson’s lawsuits are pending against Syngenta, alleging the chemical triggers neurodegeneration.
- Any label change—buffer zones, PPE upgrades or outright cancellation—would ripple through seed trait portfolios, custom-application schedules and export markets before the 2027 planting season.
Timeline of paraquat in the U.S.
- 1964: Paraquat first registered for U.S. use.
- 2016: EPA’s draft human-health assessment finds “no dietary risk” but flags occupational exposure.
- 2021: Final interim decision imposes closed-cab requirement, 24-hour re-entry interval and 100-foot residential buffer.
- 2022: Ninth Circuit Court orders EPA to re-evaluate after farm-worker groups sue.
- January 9, 2026: Zeldin signals a fresh start, demanding new data instead of relying on 1990s-era studies.
What EPA wants next
The agency will not settle for lab rat inhalation charts. It is asking for:
- Drift studies under actual Midwest wind patterns.
- Biomonitoring from mixer-loaders and flaggers wearing current PPE, not 1995-era coveralls.
- Pharmacokinetic models that factor in repeated low-dose skin contact, the dominant route for applicators.
Industry and legal fallout
Syngenta insists there is “no credible evidence” tying paraquat to Parkinson’s, but plaintiff attorneys cite a 2024 University of Guelph meta-analysis showing a 25 % increased risk in licensed applicators. A bellwether trial in Illinois state court is set for March 2026, weeks after EPA’s new data deadline. A restrictive interim decision—possible under the Federal Insecticide, Fungicide, and Rodenticide Act’s 90-day review clock—could hand plaintiffs fresh leverage in settlement talks.
What growers should watch
- Label drift: If EPA tightens the 100-foot buffer to 300 feet, edge rows on smaller farms may become un-sprayable.
- PPE costs: Requiring powered air-purifying respirators adds roughly $1,800 per applicator per season.
- Resistance plans: Losing paraquat would leave PPO inhibitors and glufosinate as the only effective alternatives for Palmer amaranth, already resistant to five modes of action.
Developer angle: data transparency
EPA’s demand for raw biomonitoring data opens a market gap for sensor and SaaS startups. Expect RFQs for:
- Wearable dermal-patch platforms that log time-stamped exposure.
- AI drift models that ingest real-time meteorological feeds from IoT weather towers.
- Blockchain audit trails to keep registrants compliant with agency record-keeping rules.
The reassessment clock is already ticking—registrants must submit new studies within 15 months. If the data gap is too wide, EPA can issue a notice of intent to cancel, turning paraquat into the next chlorpyrifos-style casualty. Stay locked to onlytrustedinfo.com for instant briefings on every filing, court ruling and label tweak as the 2027 season approaches.
